Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists
International Journal of Surgical Pathology · 2023-09 · 31 (6) · 993-1005
DOI: 10.1177/10668969221116629 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Pathology, online erschienen am 09.08.2022. Verfasst von Sambit K Mohanty und 46 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, India. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Prostatic Neoplasms, Carcinoma, Neuroendocrine, Carcinoma, Small Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Neuroendocrine differentiation in the prostate gland ranges from clinically insignificant neuroendocrine differentiation detected with markers in an otherwise conventional prostatic adenocarcinoma to a lethal high-grade small/large cell neuroendocrine carcinoma. The concept of neuroendocrine differentiation in prostatic adenocarcinoma has gained considerable importance due to its prognostic and therapeutic ramifications and pathologists play a pivotal role in its recognition. However, its awareness, reporting, and resource utilization practice patterns among pathologists are largely unknown.
Methods
Representative examples of different spectrums of neuroendocrine differentiation along with a detailed questionnaire were shared among 39 urologic pathologists using the survey monkey software. Participants were specifically questioned about the use and awareness of the 2016 WHO classification of neuroendocrine tumors of the prostate, understanding of the clinical significance of each entity, and use of different immunohistochemical (IHC) markers. De-identified respondent data were analyzed.
Results
A vast majority (90%) of the participants utilize IHC markers to confirm the diagnosis of small cell neuroendocrine carcinoma. A majority (87%) of the respondents were in agreement regarding the utilization of type of IHC markers for small cell neuroendocrine carcinoma for which 85% of the pathologists agreed that determination of the site of origin of a high-grade neuroendocrine carcinoma is not critical, as these are treated similarly. In the setting of mixed carcinomas, 62% of respondents indicated that they provide quantification and grading of the acinar component. There were varied responses regarding the prognostic implication of focal neuroendocrine cells in an otherwise conventional acinar adenocarcinoma and for Paneth cell-like differentiation. The classification of large cell neuroendocrine carcinoma was highly varied, with only 38% agreement in the illustrated case. Finally, despite the recommendation not to perform neuroendocrine markers in the absence of morphologic evidence of neuroendocrine differentiation, 62% would routinely utilize IHC in the work-up of a Gleason score 5 + 5 = 10 acinar adenocarcinoma and its differentiation from high-grade neuroendocrine carcinoma.
Conclusion
There is a disparity in the practice utilization patterns among the urologic pathologists with regard to diagnosing high-grade neuroendocrine carcinoma and in understanding the clinical significance of focal neuroendocrine cells in an otherwise conventional acinar adenocarcinoma and Paneth cell-like neuroendocrine differentiation. There seems to have a trend towards overutilization of IHC to determine neuroendocrine differentiation in the absence of neuroendocrine features on morphology. The survey results suggest a need for further refinement and development of standardized guidelines for the classification and reporting of neuroendocrine differentiation in the prostate gland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, India.
- Department of Pathology and Laboratory Medicine, Kapoor Urology Center and Pathology Laboratory, Raipur, India.
- Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
- Department of Pathology, UT Southwestern University, Dallas, TX, USA.
- Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
- Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
ORCID-Profile: Sambit K Mohanty, Anandi Lobo, Sean R Williamson, Kiril Trpkov, Adeboye O Osunkoya, Seema Kaushal, Suvradeep Mitra, Mukund Sable, Ekta Jain, Sankalp Sancheti
Zitieren
APA
Mohanty, S. K., Lobo, A., Williamson, S. R., Shah, R. B., Trpkov, K., Varma, M., Sirohi, D., Aron, M., Kandukari, S. R., Balzer, B. L., Luthringer, D. L., Ro, J., Osunkoya, A. O., Desai, S., Menon, S., Nigam, L. K., Sardana, R., Roy, P., Kaushal, S., …, & Dhillon, J. (2023). Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists. International Journal of Surgical Pathology, 31(6), 993-1005. https://doi.org/10.1177/10668969221116629
Vancouver
Mohanty SK, Lobo A, Williamson SR, Shah RB, Trpkov K, Varma M, et al. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists. International Journal of Surgical Pathology. 2023;31(6):993-1005. doi:10.1177/10668969221116629
BibTeX
@article{Mohanty2023,
author = {Mohanty, Sambit K and Lobo, Anandi and Williamson, Sean R and Shah, Rajal B and Trpkov, Kiril and Varma, Murali and Sirohi, Deepika and Aron, Manju and Kandukari, Shivani R and Balzer, Bonnie L and Luthringer, Daniel L and Ro, Jae and Osunkoya, Adeboye O and Desai, Sangeeta and Menon, Santosh and Nigam, Lovelesh K and Sardana, Rohan and Roy, Paromita and Kaushal, Seema and Midha, Divya and Swain, Minakshi and Ambekar, Asawari and Mitra, Suvradeep and Rao, Vishal and Soni, Shailesh and Jain, Kavita and Diwaker, Preeti and Pattnaik, Niharika and Sharma, Shivani and Chakrabarti, Indranil and Sable, Mukund and Jain, Ekta and Jain, Deepika and Samra, Spinder and Vankalakunti, Mahesha and Mohanty, Subhashis and Parwani, Anil V and Sancheti, Sankalp and Kumari, Niraj and Jha, Shilpy and Dixit, Mallika and Malik, Vipra and Arora, Samriti and Munjal, Gauri and Gopalan, Anuradha and Magi-Galluzzi, Cristina and Dhillon, Jasreman},
title = {Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists},
journal = {International Journal of Surgical Pathology},
year = {2023},
volume = {31},
number = {6},
pages = {993--1005},
doi = {10.1177/10668969221116629}
}
EUVIMED